Kinetic analysis of the effect of poliovirus receptor on viral uncoating: the receptor as a catalyst

Journal of Virology
S K TsangJ M Hogle

Abstract

We examined the role of soluble poliovirus receptor on the transition of native poliovirus (160S or N particle) to an infectious intermediate (135S or A particle). The viral receptor behaves as a classic transition state theory catalyst, facilitating the N-to-A conversion by lowering the activation energy for the process by 50 kcal/mol. In contrast to earlier studies which demonstrated that capsid-binding drugs inhibit thermally mediated N-to-A conversion through entropic stabilization alone, capsid-binding drugs are shown to inhibit receptor-mediated N-to-A conversion through a combination of enthalpic and entropic effects.

References

Oct 1, 1990·Journal of Virology·G KaplanV R Racaniello
Nov 5, 1989·Journal of Molecular Biology·S S KimM A McKinlay
Aug 1, 1980·Virology·L A CaliguiriG W Lawrence
Dec 8, 1995·Journal of Molecular Biology·D K Phelps, C B Post
Mar 1, 1995·Nature Structural Biology·M SmythD Stuart
Sep 15, 1993·Structure·M A OliveiraM A McKinlay
Jan 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·N H OlsonM G Rossmann
Jul 15, 1995·Structure·J K MuckelbauerM G Rossmann
Oct 1, 1996·Journal of Virology·S CurryJ M Hogle
Jun 17, 1998·Proceedings of the National Academy of Sciences of the United States of America·J K LewisG Siuzdak
Jan 5, 2000·Proceedings of the National Academy of Sciences of the United States of America·D M BelnapA C Steven
Jan 5, 2000·Proceedings of the National Academy of Sciences of the United States of America·Y HeM G Rossmann
Feb 12, 2000·Journal of Molecular Biology·S K TsangJ M Hogle
Mar 16, 2000·The EMBO Journal·L XingJ M Casasnovas
Apr 20, 2000·The Journal of Biological Chemistry·B M McDermottV R Racaniello
Feb 13, 2001·Biophysical Journal·B SpeelmanC B Post

❮ Previous
Next ❯

Citations

Nov 20, 2003·Trends in Biotechnology·Adam Zlotnick, Stephen J Stray
Jan 16, 2003·Virus Research·Peter W MasonBarry Baxt
Aug 14, 2003·Trends in Microbiology·Kartik Chandran, Max L Nibert
Nov 18, 2008·Proceedings of the National Academy of Sciences of the United States of America·Ping ZhangMichael G Rossmann
Mar 29, 2003·Journal of Virology·Yongning HeMichael G Rossmann
Dec 13, 2003·Journal of Virology·Pranav Danthi, Marie Chow
Apr 29, 2005·Journal of Virology·Markete VlasakDieter Blaas
Jun 16, 2005·Journal of Virology·Vivian O'DonnellBarry Baxt
Feb 1, 2005·Journal of Virology·Christopher M WiethoffGlen R Nemerow
May 19, 2005·Proceedings of the National Academy of Sciences of the United States of America·Yumin LiCarol Beth Post
Jul 16, 2010·Reviews in Medical Virology·Renate Fuchs, Dieter Blaas
Apr 15, 2004·Journal of Molecular Biology·Kishore KakaniD'Ann Rochon
Dec 31, 2002·Virology·Isabelle PelletierFlorence Colbère-Garapin
Jul 27, 2002·Annual Review of Microbiology·James M Hogle
Dec 15, 2006·The Journal of Chemical Physics·Yinglong Miao, Peter J Ortoleva
Jan 15, 2016·Journal of Virology·Mike StraussJames M Hogle
Jul 19, 2008·Journal of Computational Chemistry·Yinglong Miao, Peter J Ortoleva
Jan 10, 2020·Journal of Virology·Steven D Carson, Andrew J Cole
May 29, 2004·The Journal of General Virology·Magdalena T TostesonMarie Chow
Mar 18, 2003·The Journal of Biological Chemistry·Sushmita Singh, Adam Zlotnick
Aug 5, 2018·Journal of Cell Science·Jacqueline StaringThijn R Brummelkamp
Feb 25, 2021·MBio·Krishanthi S KarunatilakaJames M Hogle

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.